An enzyme capable of hydrolyzing 4-methylumbelliferyl phenyiphosphonate to 4-methylumbelliferone and phenyiphosphonicacid has been detected in human serum. It has a I value of 1.72 x 1o-mol/L,has an optimumpH of 8.8-9.1 in Tns buffer, and shows maximumactMty at 60#{176}C (30 mm). The enzymic activitycan be inhibitedby Na3PO4, EDTA, and cystemne. We saw no effect of CuSO4, adenosine, thymidine, NaN3, diethyl p-nitrophenyl All solutions were prepared in distilled water and stored at 4#{176}C. The pH of all buffers was measured at 37 #{176}C with a pH meter (Model 25; Shanghai, China).
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Materials and Methods

Reagents
Serum Samples
Normal sera were from apparently healthy blood bank donors. The blood was allowed to clot for 1-2 h at room temperature or centrifuged in a fixed-arm centrifuge at 800 x g for 15 mm. The serum samples were then stored at -28 #{176}C until needed.
Methods
Fluorogenic detection
of enzyme activity. The reaction mixture contained 0.1 mL of serum, 0.1 mL of 1 mol/L Ti-isO HC1 (pH 9.0), 0.5 mL of 1 mmol/L substrate (MUpPh, MUT, or MUP in distilled water), and 0.3 mL of distilled water or other reagents. Unless otherwise stated, the mixtures were incubated for 30 mm at 37 #{176}C in a total volume of 1 mL. The reactions were always started by adding 0.5 mL of substrate and were stopped by adding 2 mL of stop reagent (per liter, 10 mmol of EDTA, 10 mmol of Na3PO4, and 1 mol of NaHCO3).
For the substrate blanks, water instead of serum was mixed with substrate solution and run in parallel with each series. The serum blanks were also run in parallel and substrate medium was added after the stop reagent had been added. Analyzer (Abbott Labs., Abbott Park, IL). We used the absorbance method to determine the range of normal values of serum enzyme activity (U/L, defined as above) under physiological conditions. Elect rophoresis. A 7% (total, 5% methylene bisacrylamide) polyacrylamide slab gel (4 x 10 x 12 mm) in electrophoresis buffer was prepared as previously described ( The migration coefficient (Rf) for every band was calculated as Rf = FIL. In some series, slabs of acrylamide gel were cut into slices as thin as 3 mm. After each slice was incubated for 2-4 h in 1 mL of substrate-e.g., 5 mmol of MUpPh or 2 mmol of MUT per liter of 50 mmolJL Tris -HC1 (pH 9.0) containing MgCl2, 1 mmol/L-we read the fluorescence in each tube as described above.
Results
Electrophoresis.
After polyacrylmide gel electrophoresis of human serum, the enzyme activities hydrolyzing MUpPh, MUT, and MUP were developed; the results are shown in Figure 1 Figure 2 , after which the remaining activity was determined at 37#{176}C as described in Methods. Activity before incubation was taken as 100%. When diluted sera were incubated for 5 h at 37#{176}C, PDE I lost 10% of its activity, but PE was stable. Human serum kept at 60#{176}C for 1 h completely lost PDE I activity but retained about 30% of PE activity, even when the incubation period was prolonged to 5 h ( Figure   2 
The activity remaining was measured at 37#{176}C; activity before incubationwas taken as 100% E600, diethyl p.nitrophenyl phosphate; DFP, isopropyl fluorophosphate; and PCMB, p-chioromercunbenzoate. andPDE I (----) activity
Discussion
Because most workers have concurred with Kelly et al. (2) and thought that the enzymes capable of hydrolyzing the esters of phosphonic acid were PDE 1(10) , in this paper we paid special attention to establishing the nature of PE activity in human serum and its differences from PDE I. Our results for serum PDE I obtained with MUT as substrate are in agreement with previous reports, in which PDE I has been shown to require magnesium, have a pH optimum between 9.3 and 9.7 (in 
MgCI NaN3
Esenne E600
DFP PCMB
± 3 #{176}C), and no activity was lost after storage for one year at -28 #{176}C.
Kinetics of enzyme reaction. In the kinetic studies, the stated concentrations of substrate refer to the final solutions after serum was added. The kinetic procedures for PE were performed and Km and Vm were calculated from the Michaelis-Menten equation. PE in human serum has aKm of 1.72 x 10 mol/L and a Vm, of 4.44 x i0 mol-L' min1 at 37#{176}C, pH 9.0.
Effect of inhibitors.
Various compounds were examined for their effects on activity of PE and PDE I (Table  1) . PDE I was strongly inhibited by 3 mmol/L EDTA ( Figure 3) ; the subsequent addition of MgC12, 6 mmol/L, only partially restored activity, whereas PE activity was only about 40% inhibited under these same conditions. The MgC12 addition can restore PE activity to 115% (data not shown), again showing the different responses of PE and PDE I to this metal ion. Adenosine and thymidine can inhibit the activity of PDE I, but not PE, which may imply that only PDE I has a specific affinity for nucleoside.
Change in PE activity in human serum under physiological conditions. This study included 52 growing Therefore, we conclude that this enzyme cannot be classified as a PDE I and that an enzyme in human serum hydrolyzes only esters of phosphonic acid but does not attack esters of phosphoric acid and nudeotide-5'-phosphates.
On the other hand, we also confirm that PE does not belong to the usual groups of A-,B-,Cesterase or cholinesterase, because this enzyme cannot be inhibited by diethyip-nitrophenyl phosphate, isopropyl fluorophosphate, p-chloromercuribenzoate, creatinine, or eserine, which are inhibitors of those enzymes (13) .
In addition, we have also examined the range of normal values of PE in healthy humans, the change of activity during pregnancy, and changes during the growth period of children. By ages 12-15 years, PE activity in children is similar to that of adults.
Preliminary
investigations
(results not shown) showed that activities of PE were increased in patients with infectious hepatitis or cirrhosis but were unchanged in hepatic cancer, lung cancer, biliary obstruction, and hysteromyoma. Further studies on the altered expression of PE in disease states are in progress and will be described later.
